Anti-D Immunoglobulin Classification and Safety

Definition and Classification

Anti-D immunoglobulin is explicitly classified as a "pooled, biological blood product" according to international consensus guidelines, derived from pooled human plasma of hyperimmunized donors, and undergoes purification and processing from donor plasma 1

The American Society of Hematology notes that anti-D immunoglobulin may not be acceptable to certain patient populations, such as Jehovah's Witnesses, who refuse blood products, affecting treatment options 2
Current anti-D preparations show no recent evidence of HIV, HCV, HBV, or HTLV-1 transmission due to rigorous manufacturing safeguards, as stated by the National Blood Foundation 3
The product can cause hemolysis as it works by coating fetal Rh-positive red cells, with rare but serious cases of intravascular hemolysis, disseminated intravascular coagulation, and renal failure reported, according to the American College of Obstetricians and Gynecologists 1, 3
A black box warning exists for fatal intravascular hemolysis, though this remains a rare event, as warned by the FDA and the European Medicines Agency 2, 4